A high throughput splicing assay to investigate the effect of variants of unknown significance on exon inclusion
Hilary A. Scott, Emily Place, Evelyn Harper, Sudeep Mehrotra, Broad CMG, Rachel M. Huckfeldt, Jason Comander, Eric A. Pierce, Kinga M. Bujakowska
The paper develops a high throughput splicing assay (HTSA) to assess the impact of variants of unknown significance on exon inclusion, identifying 47 variants that significantly reduce exon recognition.
medRxiv · Nov 30, 2022 · PreprintGenetic & Genomic Medicine